Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial

Stellbrink, Hans-Jurgen; Schaller, Torsten; Sturm, Kerstin; Brockmeyer, Norbert H.; Potthoff, Anja; Bickel, Markus; Scholten, Stefan; Postel, Nils; Jessen, Arne; Muller, Matthias; Jager, Dirk; Muller, Christian; Seyfizadeh, Narges; Schoffel, Stefan; Ullrich, Bernd; Brosi, Laura; Kunz, Claudia; Thomas, Daniel; Laage, Rico; Hanakam, Frank; Schwab, Matthias; Schonborn-Kellenberger, Oliver; Mangold, Marina; Och, Katharina; Lehr, Thorsten; Arndt, Michaela A.; Krauss, Jurgen

Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial

Autor(en):

Stellbrink, Hans-Jurgen; Schaller, Torsten; Sturm, Kerstin; Brockmeyer, Norbert H.; Potthoff, Anja; Bickel, Markus; Scholten, Stefan; Postel, Nils; Jessen, Arne; Muller, Matthias; Jager, Dirk; Muller, Christian; Seyfizadeh, Narges; Schoffel, Stefan; Ullrich, Bernd; Brosi, Laura; Kunz, Claudia; Thomas, Daniel; Laage, Rico; Hanakam, Frank; Schwab, Matthias; Schonborn-Kellenberger, Oliver; Mangold, Marina; Och, Katharina; Lehr, Thorsten; Arndt, Michaela A.; Krauss, Jurgen

Tübinger Autor(en):

Schwab, Matthias

Erschienen in:

Pharmacological Research (2025), Bd. 221, Article 107999

Verlagsangabe:

London : Academic Press Ltd - Elsevier Science Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.phrs.2025.107999

ISSN:

1043-6618